Comparative effectiveness
VILDAGLIPTIN – A Better DPP-4 Inhibitor
The type 2 diabetes mellitus (T2DM) management has become increasingly difficult due to the progressive nature of the disease and associated comorbidities. Moreover, the limitations to...